Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Chemotherapy
Related studies linked through entity extraction aliases.
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
- Status
- RECRUITING
- Phase
- NA
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
- Status
- RECRUITING
- Phase
- PHASE2
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
- Status
- RECRUITING
- Phase
- PHASE3
Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases
- Status
- COMPLETED
- Phase
- N/A
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers (TOG/GI-SAFRADJU-2501)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Clinical Study on the First-line Treatment of Metastatic Pancreatic Cancer With TQB2916 Injection Combined With Gemcitabine Hydrochloride for Injection and Paclitaxel for Injection (Albumin-bound Type)
- Status
- RECRUITING
- Phase
- PHASE2
Tumor Local Excision +Postoperative Adjuvant Chemoradiotherapy for T1-2N0M0 Low/Ultra-Low Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- N/A
AK129 Combination Therapy for Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Arsenic Trioxide With MAPK Inhibitors and Chemotherapy for Stage 4/M Neuroblastoma
- Status
- RECRUITING
- Phase
- PHASE2